Home > Healthcare > Biotechnology > Biotechnology R&D > DNA Synthesis Market

DNA Synthesis Market Size

  • Report ID: GMI6000
  • Published Date: Aug 2024
  • Report Format: PDF

DNA Synthesis Market Size

DNA Synthesis Market size was valued at USD 4 billion in 2023 and is projected to witness growth at a CAGR of 18.9% between 2024 and 2032. High market growth can be attributed to the advancements in synthetic biology and gene editing technologies such as CRISPR, coupled with growing adoption of precision medicine.

 

The growing emphasis on synthetic biology research is primarily driven by robust support for DNA synthesis initiatives, marked by substantial investments in R&D, alongside an expanding focus on DNA studies. For instance, in April 2023, NunaBio, a TechBio company specializing in synthetic DNA for research, secured USD 2.4 million in a seed round, supported by the Northeast Innovation Fund and the European Regional Development Fund.
 

The company is focused on innovating a groundbreaking approach to DNA synthesis, facilitating the efficient and cost-effective production of oligonucleotides on a large scale, with remarkable speed and precision. Thus, such growing research funding aimed to support and catalyze the development of technology, fosters the potential of synthetic biology across the genome sector, thereby propelling the market growth.
 

DNA synthesis is the process of artificially creating DNA molecules. It involves chemically synthesizing nucleotide sequences in the laboratory, that can be used for various applications such as genetic engineering, research, and biotechnology.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The DNA synthesis market was valued at USD 4 billion in 2023 and is projected to witness a 18.9% CAGR between 2024 to 2032, attributed to the advancements in synthetic biology and gene editing technologies.

Oligonucleotide synthesis service segment held 58% share of DNA synthesis in 2023 and will grow rapidly through 2032, due to its crucial role in various applications, including genetic testing, molecular diagnostics, synthetic biology, and gene editing.

North America DNA synthesis market held a revenue share of 36.5% in 2023 and is anticipated to record 18.4% CAGR through 2032, owing to the region

BIOMATIK, Bioneer Corporation, Eton Bioscience, Inc, Eurofins Scientific, GenScript Biotech Corporation, IBA Lifesciences GmbH, Integrated DNA Technologies, Inc. among others.

DNA Synthesis Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 16
  • Tables & Figures: 389
  • Countries covered: 20
  • Pages: 225
 Download Free Sample